HearUSA Recognized as a Top Hearing Care Retailer for Third Consecutive Year
HearUSA has been recognized for the third year in a row on Newsweek’s America’s Best Retailers list.
Read MoreHearUSA has been recognized for the third year in a row on Newsweek’s America’s Best Retailers list.
Read MoreBritish and Irish Q2 data on hearing technology market figures for 2025 shows a reduction in private, public, and ROI hearing aid sales.
Read MoreResearchers have adapted the low-cost OCT imaging method developed for ophthalmology and used it to visualize tiny structures in the human inner ear.
Read MoreNo disruption to existing services for Oticon customers is expected.
Read MoreHIA’s MarkeTrak 2025 study of the U.S. hearing loss market provides new data on prescription hearing aids, OTC devices, and emerging technologies.
Read MoreReSound Enzo IA is a very small rechargeable Super Power hearing aid for people with severe to profound hearing loss.
Read MorePhonak’s new Virto R Infinio is its most compact rechargeable custom in-the-ear hearing aid powered by the advanced Infinio technology.
Read MoreThe EUHA ticket shop for the 69th International Congress of Hearing Aid Acousticians and the...
Read MoreTechmi Match is an in-ear OTC hearing aid created to seamlessly blend cutting-edge technology with modern, sleek design.
Read MoreThe 2025 AudBoss Private Practice Summit will bring together hearing care professionals for networking, education, and practical strategies to boost private practice success.
Read MoreBIHIMA’s EuroTrak UK 2025 survey reveals rising satisfaction among hearing device users, but also a slight dip in adoption.
Read MoreThis is an updated guide to aid HCPs in educating patients about assistive listening systems.
Read MoreA long-term U.S. study has found that young adults with hearing loss—especially of certain ethnicities—face lower educational attainment, reduced employment rates, and diminished income compared to their peers without hearing loss.
Read MoreGlobo Language Solutions, a B2B provider of interpreting and translation services, has been named a 2025 Silver Stevie Award winner.
Read MoreSENS-501 is a gene therapy candidate being developed to treat a form of congenital deafness linked to mutations in the OTOF (otoferlin) gene.
Read More